Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain SYK message board posts where the ticker symbol SYK has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest SYK SEC Filings

Filings Format Description Filing Date File/Film Number
8-K  Documents Current report, items 5.03 and 9.01
Acc-no: 0000310764-18-000191 (34 Act)  Size: 125 KB
2018-08-06 000-09165
18995354
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000310764-18-000188 Size: 6 KB
2018-08-02
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000310764-18-000187 Size: 4 KB
2018-08-02
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0000310764-18-000185 (34 Act)  Size: 7 MB
2018-07-25 000-09165
18968761
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0000310764-18-000181 (34 Act)  Size: 723 KB
2018-07-24 000-09165
18966637
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000310764-18-000177 Size: 5 KB
2018-07-10
8-K  Documents Current report, item 5.02
Acc-no: 0000310764-18-000175 (34 Act)  Size: 112 KB
2018-07-10 000-09165
18945859
8-K  Documents Current report, item 7.01
Acc-no: 0000310764-18-000171 (34 Act)  Size: 90 KB
2018-06-13 000-09165
18895894
SD  Documents Acc-no: 0000310764-18-000169 (34 Act)  Size: 956 KB 2018-05-31 000-09165
18871101
3/A  Documents [Amend] Initial statement of beneficial ownership of securities
Acc-no: 0000310764-18-000167 Size: 7 KB
2018-05-17
More SYK SEC Filings


Related news from
Sat, 11 Aug 2018
12:01:41 +0000
See what the IHS Markit Score report has to say about Stryker Corp.
Stryker Corp NYSE:SYK
Thu, 09 Aug 2018
13:01:21 +0000
What Does Tandem Diabetes Care’s Valuation Trend Indicate?
From $8.80 on May 8, Tandem Diabetes Care’s (TNDM) stock price steadily rose to a high of $33.44 on August 3. It recovered after that to its current level of $30.75.
Thu, 09 Aug 2018
12:24:14 +0000
Gauging Dentsply Sirona’s Valuation Trend and Recent Acquisitions
Dentsply Sirona (XRAY) has lowered its guidance for fiscal 2018. It now expects adjusted EPS of $2–$2.15 compared to the previous estimate of $2.55–$2.65. The decrease represents Dentsply’s expectation of a decline in revenue for the remainder of 2018, driven by higher levels of inventory destocking at its dealer partners.
Thu, 09 Aug 2018
12:24:13 +0000
Dentsply Sirona’s Segments: Q2 2018 Performance
Since its second-quarter earnings release on July 7, Dentsply Sirona (XRAY) stock has plummeted ~20%. In this series, we’ll explore its financial performance, how its segments are performing, its recent acquisitions, its valuation metrics, and what analysts expect in the coming months. Dentsply Sirona is a leading global manufacturer of professional dental products and technologies.
Thu, 09 Aug 2018
12:15:00 +0000
Market Trends Toward New Normal in ING Group, N.V, Altaba, Steel Dynamics, The TJX Companies, Colgate-Palmolive, and Stryker — Emerging Consolidated Expectations, Analyst Ratings
NEW YORK, Aug. 09, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ING ...
Tue, 07 Aug 2018
14:24:02 +0000
DENTSPLY (XRAY) Beats on Q2 Earnings, Lowers 2018 Guidance
DENTSPLY (XRAY) gains from solid year-over-year international revenue growth in Q2; high impairment charges in the quarter mars results.
Mon, 06 Aug 2018
11:33:04 +0000
Hologic Expects Robust Earnings Growth for Fiscal 2018
In its fiscal third-quarter conference call, Hologic (HOLX) narrowed the projected range of its fiscal 2018 EPS from $2.22–$2.27 to $2.24–$2.26. Considering the midpoint of the updated EPS guidance range, the company expects YoY (year-over-year) EPS growth of ~10.8% for fiscal 2018. 
Fri, 03 Aug 2018
20:45:02 +0000
Hologic Raised Its Revenue Guidance for Fiscal 2018
During its fiscal third quarter conference call, Hologic (HOLX) raised its fiscal 2018 non-GAAP revenue guidance from $3.18 billion–$3.21 billion to ~$3.21 billion–$3.22 billion. So, its YoY (year-over-year) reported revenue growth rate for fiscal 2018 is expected to be 4.8%–5.3%, higher than the previously projected range of 4.0%–4.9%. 
Fri, 03 Aug 2018
19:10:32 +0000
Analysts’ Recommendations for Hologic and Its Peers in August
In the fiscal third quarter, Hologic reported non-GAAP EPS of ~$0.58, which was a YoY rise of 16.0%. Hologic surpassed its revenue and EPS guidance for the fiscal third quarter. Hologic’s Diagnostics business posted a recovery compared to the fiscal second quarter, and its Surgical business has posted gradual improvement since the fiscal first quarter.
Fri, 03 Aug 2018
16:15:04 +0000
Medical Product Stock Earnings on Aug 6: CAH, HSIC & More
The Medical product market gains momentum owing to the recent two-year suspension of the controversial 2.3% Medical Device tax.
Fri, 03 Aug 2018
13:58:01 +0000
Pacific Biosciences (PACB) Loss In Line With Estimates in Q2
Strong performance in Product revenues boosts Pacific Biosciences (PACB) in Q2. Sequel order improves year over year.
Fri, 03 Aug 2018
13:50:01 +0000
DexCom (DXCM) Beats Q2 Earnings Estimates, Raises '18 View
Solid contribution from the Sensor, Transmitter and Receiver segments drives DexCom's (DXCM) Q2 results.
Fri, 03 Aug 2018
12:48:12 +0000
Integer Holdings (ITGR) Beats on Q2 Earnings, '18 View Solid
Integer Holdings (ITGR) gains on solid Cardio & Vascular revenues and high organic sales; a solid guidance raises optimism.
Thu, 02 Aug 2018
16:21:04 +0000
DaVita (DVA) Beats Earnings and Revenue Estimates in Q2
Year-over-year growth in net dialysis and related lab patient service revenues boost DaVita's (DVA) bottom line in Q2.
Thu, 02 Aug 2018
14:45:02 +0000
Express Scripts (ESRX) Q2 Earnings Beat, Network Claims Fall
Express Scripts (ESRX) witnesses year-over-year decline in adjusted network claims in Q2, thanks to the loss of certain public sector clients.
Thu, 02 Aug 2018
14:42:02 +0000
AmerisourceBergen (ABC) Beats on Q3 Earnings & Revenues
AmerisourceBergen (ABC) registers strong growth in the Pharmaceutical Distribution segment and the World Courier business in Q3.
Wed, 01 Aug 2018
13:03:01 +0000
Fresenius Medical (FMS) Misses Q2 Earnings & Sales Estimates
Lower peritoneal dialysis sales in Q2 hurt Fresenius Medical (FMS); solid geographical performance encourages.
Wed, 01 Aug 2018
12:20:12 +0000
Medical Product Earnings Lineup for Aug 2: ABC, BDX & More
Strong R&D focus is likely to be the key driver of the Medical Product space in Q2.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "ValueForum has been a life changer for me. Due to the generosity of a remarkable group of people I quit work at the age of 53 to invest/trade full time. ValueForum is like having a thousand set of eyes watching the markets for you, there is no way an individual working alone could begin to keep up with all the information that as a member of this group you are able to keep up with. Take my right arm but don't take my ValueForum!" more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards